CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-11 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +1,562 | 6,875 | ||
| 2025-02-11 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −791 | $57.51 | $45K | 6,084 |
| 2025-02-11 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −3 | $57.54 | $173 | 6.08 |
| 2025-02-11 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units 10b5-1 | −1,562 | 0 | ||
| 2025-02-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +2,031 | 6,440 | ||
| 2025-02-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,023 | $57.51 | $59K | 5,417 |
| 2025-02-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −4 | $57.50 | $230 | 5,413 |
| 2025-02-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units 10b5-1 | −2,031 | 0 | ||
| 2025-02-10 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,894 | $58.39 | $111K | 6,704 |
| 2025-02-10 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −2,295 | $59.34 | $136K | 4,409 |
| 2025-02-09 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +2,656 | 5,313 | ||
| 2025-02-09 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 2,656 | ||
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +3,437 | 4,409 | ||
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +4,189 | $6.80 | $28K | 8,598 |
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units 10b5-1 | −3,437 | 3,437 | ||
| 2025-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,189 | 21,601 |
Page 19 of 19 · 376 trades